BACKGROUND: Resistance to platinum-based drugs represents a major obstacle for the management of high-grade serous ovarian cancer (HGSOC) patients. Indeed, the selective pressure of platinum-based (PT) chemotherapy often leads to the outgrowth of platinum-resistant subclones. In this scenario, the underlying adaptive networks should be fully investigated to provide advances toward more streamlined and personalized care. METHODS: We conducted a comprehensive analysis of Pin1/Notch3relationship from HGSOC cell lines and primary tumours, integrating multiple genetic targeting under chemotherapy pressure, differential proteomic approaches, molecular docking data and dynamics simulations, thus identifying a functional circuit evaluated in vitro and in vivo models.We conducted a comprehensive analysis of relationship from HGSOC cell lines and primary tumours, integrating multiple genetic targeting under chemotherapy pressure, differential proteomic approaches, molecular docking data and dynamics simulations, thus identifying a functional circuit evaluated in vitro and in vivo models. RESULTS: Here, we demonstrated that carboplatin treatment of HGSOC cells promoted the activation of the Pin1/Notch3 axis, resulting in platinum resistance. Accordingly, HGSOC-bearing patients showing increased Pin1/Notch3 co-expression after PT-based chemotherapy correlated with a clinical worse response. Conversely, genetic targeting of Pin1 combined with carboplatin treatment sensitizes resistant cells to platinum-based therapy, both in vitro and in vivo, strongly reducing their Notch3-mediated metastatic potential in preclinical murine models. Mechanistically, Pin1-Notch3 binding favours protection of Notch3 from its GSK3β-mediated degradation, resulting in increased Notch3 expression. CONCLUSIONS: Collectively, our findings identify the functional Pin1/Notch3 axis as an escape strategy from chemotherapy-induced cell death, thus suggesting a novel predictive role of the Pin1/Notch3 axis in the platinum response, which could be useful for implementing frontline treatments for HGSOC patients before recurrence.
Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer.
阅读:3
作者:Giuli Maria Valeria, Mancusi Angelica, Natiello Bianca, Di Cristofano Samuele, Reali Rebecca, Pignataro Maria Gemma, D'Andrea Daniel, Di Magno Laura, Nicoletti Carmine, Giorgi Alessandra, Macone Alberto, Camerini Serena, Casella Marialuisa, Peruzzi Giovanna, Zema Sabrina, Canettieri Gianluca, Tomao Federica, Palaia Innocenza, Pernazza Angelina, Rustighi Alessandra, Palermo Rocco, Raimondo Domenico, Monti Alessandra, Doti Nunzianna, d'Amati Giulia, Del Sal Giannino, Screpanti Isabella, Talora Claudio, Bellavia Diana, Checquolo Saula
| 期刊: | Journal of Experimental & Clinical Cancer Research | 影响因子: | 12.800 |
| 时间: | 2026 | 起止号: | 2026 Feb 11; 45(1):71 |
| doi: | 10.1186/s13046-026-03658-x | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
